Conjugation of a diabetes drug with a brush polymer reduces the reactivity of the drug conjugate towards pre-existing polymer antibodies in human plasma and improves the drug's performance in diabetic mice.
References
Leader, B., Baca, Q. J. & Golan, D. E. Nat. Rev. Drug Discov. 7, 21–39 (2008).
Walsh, G. Nat. Biotechnol. 32, 992–1000 (2014).
Swierczewska, M., Lee, K. C. & Lee, S. Expert Opin. Emerg. Drugs 20, 531–536 (2015).
Lubich, C. et al. Pharm. Res. 33, 2239–2249 (2016).
Qi, Y. et al. Nat. Biomed. Eng. 1, 0002 (2016).
Park, E. J., Lim, S. M., Lee, K. C. & Na, D. H. Expert Opin. Ther. Patents 26, 833–842 (2016).
Kim, T. H. et al. Bioconjug. Chem. 23, 2214–2220 (2012).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Lee, K., Lee, S. Drug delivery: Brushing off antigenicity. Nat Biomed Eng 1, 0019 (2017). https://doi.org/10.1038/s41551-016-0019
Published:
DOI: https://doi.org/10.1038/s41551-016-0019
- Springer Nature Limited